Medical Devices Today

IN3 Conferences Partner Medtech Innovators with Top Investors & Corporate Acquirers

 

June 9-11, 2010

The Westin Copley Place, Boston

Safety Features Should Be Standard On CT, Fluoro Devices, Docs Say

Article preview from "The Gray Sheet" - April 26, 2010

In the same way seatbelts and airbags are mandatory for all cars, available technologies for reducing radiation dose should be required for all medical imaging equipment that uses ionizing radiation, the Society of Interventional Radiology argues.

Medical Device Earn-Outs More Common As Buyers Hedge Bets

Article preview from Start Up - April, 2010

A review of mergers-and-acquisitions data in our Elsevier Strategic Transactions database suggests that strategic buyers are more interested than ever in hedging their bets by structuring acquisitions around earn-out payments, which come due once the acquired company delivers on its promises.

Bioactive Technologies for Bone Replacement

Article preview from Medtech Insight - April, 2010

The global market for orthobiologics, comprised primarily of bone replacement materials, reached almost $2 billion in 2009 and is growing at an overall rate of 7%. Medtronic leads in bone replacement with a 45% market share, but overall growth in orthobiologics may come from emerging segments, particular synthetic and stem-cell based technologies.

Health Care Reform: Further Taxing The Device Innovation Model

Article preview from IN VIVO -  March/April, 2010

The tax on medical devices was a late addition to the health reform legislation but it quickly became the industry's focal point over concerns that, in an already difficult environment, this added burden could threaten to disrupt the traditional device innovation model.

Medicare Inpatient Proposal: No Near-Term Trouble Spots For Device Sector

Article preview from "The Gray Sheet" - April 26, 2010

Medicare reimbursement rates for most device-intensive hospital procedures would increase moderately next year even as overall payments to hospitals would decline under CMS' fiscal year 2011 inpatient 1 proposed rule, issued April 19.

Stryker, Howmedica Unit Exonerated In Hip-Implant Suit

 

Boston Scientific Defibrillator Plea Bargain Rejected By U.S. Judge

Siemens, Philips, Toshiba, GE PET Scans Grow By Third Per Year

Abbott Patent Fight With BD Leads To Wider Appeals Court Review

Boston Sci Tech Chief Retires With Fat Package, Citing ‘Family Reasons’

Medtronic’s Update Of PoleStar Brain Surgery Device Cleared By FDA

Covidien Recalls Tracheostomy Tubes Following Three Deaths

Baxter, Other Infusion Pumps Subject Of FDA Probe Following Deaths

Medtronic Big Enough To Deal With FDA Delays, Smaller Firms To Suffer

Medtronic Recalls Heart Monitors, Emergency Defibrillators For Wiring

Smith & Nephew Cleared For 30-Year Claim On Knee Implant

J&J Orders $1.9 Million Quality Assurance Technology From Sciemetric

Boston Sci, Medtronics, Others Face Small Firms Eying PV Market

Medtronic Completes Buyout Of Invatec Heart-Device Competitor

Bigger, Tougher, Faster: Preparing for the New FDA

Bigger, Tougher, Faster: Preparing for the New FDA
When the inspector comes calling ... will you be ready?

Elsevier Business Intelligence announces the publication
of a new 16-page special Report: Bigger, Tougher, Faster: Preparing for the New FDA - When the inspector comes calling ... will you be ready? Originally published in "The Silver Sheet"

The Future of Connected Health

Article preview from Medtech Insight - March, 2010

To succeed in today's market, medical devices not only have to incorporate the latest technology, they also must have the ability to treat patients in the safest and most affordable fashion. A number of efforts in this area are underway, including the movement for "connected health," which requires medical devices to be able to communicate with other devices or systems in the expanding and remote health care arena. In a recent interview, Medtech Insight spoke about the changing environment with Pamela McNamara, president of US operations at Cambridge Consultants Inc. She notes that a medical device is only a single component in a much larger system of operation, and manufacturers need to develop and improve products with that in mind.

Baxter Spends Big on ApaTech to Join Orthobiologics Fray

Article preview from IN VIVO -  February/March, 2010

Baxter International Inc. brought its full and considerable weight to bear to the orthobiologics market by paying handsomely for Apatech Inc., a privately held start-up with a silicate substituted calcium phosphate synthetic bone graft material.